ScholarLens Back to search
2005•Foreign Medical SciencesRequires access

The clinical value of CA19-9 and CEA in diagnosing pancreas cancer

Chen Bing-hui

Open publisher page 0 citations

Abstract

Objective To investigate the clinical value of the tumor marker CA19-9 and carcinoembryonic antigen(CEA) in human serum in diagnosis of pancreas cancer.Methods The concentrations of CA19-9 and CEA in serum in thirty-two patients with pancreas cancer and thirty-two patients with benign pancreatic disease were detected with Elecsys 1010 auto electrochemiluminescene immune analyzer.Results The levels of CA19-9 and CEA in the former group were (106.3±79.1)ng/ml and (7.2±0.7)ng/ml ,which were significantly higher than those in the latter group.Conculsion The value of CA19-9 in diagnosing of pancreas cancer is higher than that of CEA .But the combined detection of CA19-9 and CEA is clinically significant to diagnosis of pancreas cancer .

About this research paper

What this paper is about

Objective To investigate the clinical value of the tumor marker CA19-9 and carcinoembryonic antigen(CEA) in human serum in diagnosis of pancreas cancer.Methods The concentrations of CA19-9 and CEA in serum in thirty-two patients with pancreas cancer and thirty-two patients with benign pancreatic disease were detected with Elecsys 1010 auto electrochemiluminescene immune analyzer.Results The levels of CA19-9 and CEA in the former group were (106.3±79.1)ng/ml and (7.2±0.7)ng/ml ,which were significantly higher than those in the latter group.Conculsion The value of CA19-9 in diagnosing of pancreas cancer is higher than that of CEA .But the combined detection of CA19-9 and CEA is clinically significant to diagnosis of pancreas cancer .

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the clinical value of the tumor marker CA19-9 and carcinoembryonic antigen(CEA) in human serum in diagnosis of pancreas cancer.Methods The concentrations of CA19-9 and CEA in serum in thirty-two patients with pancreas cancer and thirty-two patients with benign pancreatic disease were detected with Elecsys 1010 auto electrochemiluminescene immune analyzer.Results The levels of CA19-9 and CEA in the former group were (106.3±79.1)ng/ml and (7.2±0.7)ng/ml ,which were significantly higher than those in the latter group.Conculsion The value of CA19-9 in diagnosing of pancreas cancer is higher than that of CEA .But the combined detection of CA19-9 and CEA is clinically significant to diagnosis of pancreas cancer .

Key concepts: Carcinoembryonic antigen, CA19-9, Medicine, Pancreas, Pancreatic cancer, Internal medicine, Tumor marker, Cancer

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
The clinical value of CA19-9 and CEA in diagnosing pancreas cancer — Research Paper | ScholarLens